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Background: The split-liver technique provides a good left lateral graft in children, but its results in
adults remain controversial.
Methods: From 1992 to 2007, 37 patients received 38 cadaveric right-sided grafts. Donors and recipi-
ents were selected for good quality grafts and elective indications; the latter included a high proportion
of tumour cases and primary sclerosing cholangitis. Grafts included 31 extended right grafts (ERGs;
segments IV–VIII and I and the inferior vena cava [IVC]) and seven right grafts (RGs; segments V–VIII)
including five without the IVC and middle hepatic vein (MHV).
Results: Mortality was 5% (two patients). There were four retransplantations (11%) for arterial throm-
bosis (1), portal vein thrombosis (2) and primary non-function (1). The retransplantation rate was higher in
RG than in ERG (three vs. one patient; P = 0.015). Of the five patients without MHV, three were
retransplanted and one had small-for-size syndrome leading to late death. After a mean follow-up of 5
years, 1-, 3- and 5-year graft and patient survival rates were 84%, 80% and 71%, and 91%, 88% and
78%, respectively. One-year patient and graft survival rates after ERG transplantation were 96% and
92%, respectively.
Conclusions: Split-liver transplantation is a safe alternative to whole organ transplantation when an
ERG is carried out. Right graft is associated with increased risk of graft loss, especially if the MHV is
omitted. Split-liver transplantation with an ERG offers excellent outcomes and should be encouraged
when good quality grafts are available.
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Introduction
Split-liver transplantation (SLT), which provides two grafts from
one donor, has been developed in response to the shortage of
donors with the aim of reducing the number of deaths of patients
on the waiting list.1–3 Despite obvious benefits, its spread has been
limited by technical and logistical problems and by controversial
outcomes.4–8 It clearly provides excellent left lateral grafts (LLGs) in
children, who would require a reduced size graft in any case.9,10 By
contrast, the results of SLT in adults remain controversial.4–8 Early
series reported increased morbidity and graft loss rates in compari-
son with full liver transplantation.3,11,12 Recent studies have shown
that excellent results can be achieved with improved technique
and better donor and recipient selection.13,14 However, three large
cohort studies reported that split and reduced grafts were associ-
ated with increased risk for mortality and retransplantation.4,5,7 At
present, only a minority of centres routinely perform SLT4 and its
use is largely limited to child + adult pairs of recipients.
The technique for SLT is not codified and many aspects of it are
still debated, such as in situ vs. ex situ procedures and parenchymal
and vascular sharing.14,15 The most frequent procedure is the left*These authors contributed equally to this work.
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lateral (segments II, III)/extended right (segments I, IV–VIII)
graft combination for a child + adult pair. The inclusion of seg-
ments IV and I increases the volume of the parenchyma, but may
involve a risk for septic complications as a result of inadequate
vascular supply and biliary drainage of these segments.16 Another
possibility is the left liver (segments II–IV)/right liver (segments
V–VIII) graft combination for a two-adult or a large child + adult
pair of recipients. In such cases, the middle hepatic vein (MHV)
can accompany the right or the left liver graft, which puts the graft
deprived of the MHV at higher risk.17
The aim of this study is to evaluate outcomes of right-sided
split-liver grafts in adult recipients, with special reference to tech-
nical issues, such as ex situ procedure, inclusion of segments IV
and I and MHV omission.
Materials and methods
All adult patients (aged >18 years) undergoing SLT with right-
sided grafts were included in this monocentric retrospective study.
Two types of grafts were used; these were defined as extended right
grafts (ERGs), which included segments IV–VIII and I, and right
grafts (RGs), which included segments V–VIII with or without
the MHV. All but three left grafts were transplanted in another
hospital, mainly in paediatric recipients.
Recipient selection criteria for SLT
Informed consent about the possibility of split-liver graft was
obtained from all patients during pre-transplant evaluation.
Split grafts were used preferentially in patients with a tumour
indication or a stable liver condition, although end-stage patients
were also included. Prior to 2000, ERG recipients were selected
for a weight match with the donor. From 2000, the selection was
based on an expected graft to recipient weight ratio >0.8%.
Donor selection criteria for splitting
Donor criteria for the splitting procedure included: age <60 years;
body mass index (BMI)30 kg/m2; stable haemodynamic condi-
tions; normal liver function tests, and absence of steatosis.
Most split grafts were performed in adult + child recipient pairs.
In France, since June 2004 livers from donors aged <30 years have
been systematically offered to paediatric recipients and evaluated
by a paediatric transplant team. If SLT is decided upon, an ERG or
RG is offered to an adult unit for transplantation to any recipient
chosen by the team.
Harvesting and liver-splitting procedures were performed by
the same team, whether the adult or paediatric team, using iden-
tical techniques developed together over the years. Split proce-
dures for two adults were occasionally considered when a large
graft and two small-sized recipients were available.
Splitting procedures
Ex situ procedures
Liver procurement was performed according to standard
techniques of multiple organ retrieval. All grafts were perfused
through the aorta and the portal vein with University of Wis-
consin (UW) preservation solution. The bile duct was flushed
with the UW solution.
Arteries were identified by inspection and probing and the
portal vein was dissected up to the bifurcation. The hepatic veins
were explored from inside the inferior vena cava (IVC) lumen.
Graft cholangiography and arteriography were performed earlier
in the series, but have not been used recently. The portal and
arterial branches were divided extrahepatically, whereas the bile
ducts were divided at the hilar plate level during transection.
Hepatic veins were divided at their termination into the IVC. The
graft transection plane was decided according to features of both
recipients. In adult + child pairs, the split procedure resulted in an
LLG (segments II and III) and an ERG. In such cases, the ERG
included the right branch of the hepatic artery, the portal trunk
and the common bile duct. The left hepatic vein remained with
the left graft and the right and middle hepatic veins (RHV and
MHV), and the IVC, remained with the ERG. In two-adult cases,
the split procedure resulted in full left and full right grafts. In such
cases the RG was identical to a live donor graft (i.e. it included the
right arterial and portal branches, no IVC and usually no MHV).
The liver was divided along the falciform ligament or along
Cantlie’s line according to the planned splitting procedure. Paren-
chymal transection was performed by kellyclasia. Sutures were
applied to all visible vessels. Early in the series, 5 ml fibrin glue
(Tissucol™; Baxter Healthcare, Vienna, Austria) were applied on
the raw cut surface, but more recently collagen sponge with
coagulation factors (Tachosil™; Nycomed, Zurich, Switzerland)
was applied in the recipient at revascularization.
In situ procedures
In situ procedures provided ERG + LLG pairs and were performed
according to the technique used in living-donor left lateral
sectionectomy for paediatric transplantation, except that the
common hepatic artery remained with the left graft. In summary,
the liver hilum was dissected and the hepatic artery and portal
vein isolated. Transection was performed without clamping on the
right side of the falciform ligament using kellyclasia or a harmonic
scalpel.
Liver transplantation procedure
Total hepatectomy was performed whenever possible with preser-
vation of the IVC and a temporary portocaval shunt was routinely
applied.18 In grafts including the IVC, outflow reconstruction was
performed by end-to-end anastomosis between the graft IVC and
the joined stumps of the three native hepatic veins (piggyback
technique) using running 4/0 prolene sutures. In RG without the
IVC, direct anastomosis of the graft RHV to the side of the native
IVC was used. Inflow reconstruction included end-to-end portal
vein anastomosis with running 5/0 prolene sutures and end-to-
end arterial anastomosis between the graft and recipient right
branches with 7/0 or 8/0 monofilament interrupted sutures under
magnification. Standard biliary reconstruction was performed
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using duct-to-duct anastomosis with 6/0 absorbable sutures.
A T-tube was inserted in selected cases. Roux-en-Y choledocoje-
junostomy was performed in patients with primary sclerosing
cholangitis (PSC) or when the bile duct was not usable.
Study outcomes
Surgical results, postoperative course and patient and graft
survival rates at 1, 3 and 5 years were studied. Expected graft
survival according to the donor risk index7 was computed. Out-
comes according to different graft features were compared.
Continuous variables were compared using the unpaired t-test
or Mann–Whitney U-test, as appropriate; categorical variables
were compared using the chi-squared test or Fisher’s exact test, as
appropriate. Patient and graft survival rates were calculated using
the Kaplan–Meier method and compared using the log-rank test.
Results
From January 1992 to December 2007, 38 (6.3%) of 600 liver
transplantations were performed in 37 patients using right-sided
grafts. Thirty-three cases (87%) were operated after 1999.
Donor and graft features
The median donor age was 23 years (range 13–59 years) and 24
(63%) donors were <30 years old; 29 were male and nine were
female. Harvesting was performed ex situ in 33 cases and in situ
in five. The splitting procedure provided 31 ERGs and seven RGs
(Table 1). The mean graft : recipient weight ratio was 1.2  0.4
(range 0.7–1.5). Considering left grafts, 33 were transplanted in
children at another hospital. In the remaining five cases, splitting
procedures generating full right-full left grafts were used for two
adult recipients, transplanted locally in three cases.
Recipient features
Recipients of split grafts included 30 men and eight women with
a median age of 56 years (range 23–68 years). Twenty (53%)
patients had Model for End-stage Liver Disease (MELD) score
<15.
Indications for transplantation are reported in Table 2. Hepa-
tocellular carcinoma (HCC) was present in a majority of patients
(54%), whereas cirrhosis without HCC accounted for only 24%
of cases. As Table 2 shows, the proportion of HCC patients who
received a split graft was significantly higher than that of cirrhotic
Table 1 Features of the 38 right split grafts with their attached vascular and biliary structures
n IVC MHV Coeliac trunk RHA PV RPB CBD
Ex situ
ERG 26 26 26 0 26 20 6 26
RG 7 4 2 0 7 5 2 7
In situ
ERG 5 5 5 0 5 5 0 5
ERG, extended right graft; RG, right graft; IVC, inferior vena cava; MHV, middle hepatic vein; RHA, right hepatic artery; PV, portal vein; RPB, right portal
branch; CBD, common bile duct
Table 2 Indications for split-liver transplantation (SLT) and proportion of procedures carried out between 1992 and 2007 according to
indication
Indications for SLT (n = 38)
Primary transplantation 36
Hepatocellular carcinoma 20
End-stage cirrhosis 8
Primary sclerosing cholangitis 6a
Peripheral cholangiocellular carcinoma 1
Rendu–Osler disease 1
Retransplantation 2
Portal vein thrombosis 1a
Chronic rejection 1
Indications for liver transplantation 1992–2007 (n = 600)
Overall SLT P-value
End-stage cirrhosis 283 8 (2.8%)
Hepatocellular carcinoma 197 20 (10.2%) P = 0.0008 vs. cirrhosis
Primary sclerosing cholangitis 22 6 (27.3%) P < 0.0001 vs. cirrhosis; P = 0.019 vs. hepatocellular carcinoma
aPatient retransplanted with another split graft
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patients (10.2% vs. 2.8%, respectively; P = 0.0008) In addition, a
high proportion of patients with PSC received a split graft
(27.3%) compared with HCC and cirrhotic patients (P = 0.019
and P < 0.0001, respectively). Split grafts were used for two
retransplantations, one for portal vein thrombosis (PVT) at day 1
after SLT using an ERG in a patient with PSC, and one for chronic
rejection 3 years after full graft transplantation.
Surgical data
Temporary portocaval shunt was performed in 31 cases. The
recipient IVC was preserved in all but five cases. The IVC was
resected in two patients at the beginning of our series in line with
standard procedure at the time, and in three patients for technical
reasons (retransplantation, segment I encircling the IVC, and pre-
vious resection of segments VI, VII and I which prevented the
dissection of the anterior aspect of the IVC).
Technical variants according to graft and recipient characteris-
tics are reported in Table 3. Inferior vena cava implantation was
performed in piggyback fashion except in cases of IVC replace-
ment. In the three RGs deprived of IVC, direct venous anastomo-
sis was performed in association with the reconstruction of MHV
tributaries of segments V and VIII using donor iliac vein graft
interposition in one case and implantation of an inferior RHV
in one case. Direct portal vein and arterial anastomoses were
performed in 36 and 35 cases, respectively. Vascular grafts were
required in four patients. One patient had end-to-end anastomo-
sis with recipient portal vein after lengthening of the donor right
portal branch by iliac vein. In three patients the recipient right
branch of the hepatic artery could not be used for anastomosis
because of its small calibre or poor quality. Iliac artery grafts were
interposed between the donor right branch of the hepatic artery
and the common hepatic artery, the splenic artery or the supra-
coeliac aorta, in one case each. One patient with extended throm-
bosis of the portal trunk required a porto-mesenteric bypass with
a ringed polytetrafluoroethylene (PTFE) graft interposition.
Median cold ischaemic time was 10 h (range 4–15 hours); ex situ
procedures took longer than those carried out in situ (10 h vs. 8 h;
P=0.005),as did RGs compared with ERGs (11 h vs.10 h;P=0.04).
The median durations of hepatectomy and transplantation were
85 min (range 35–170 min) and 420 min (range 330–900 min),
respectively. Median blood loss was 2000 ml (range 500–9000 ml).
Blood transfusions were required in 31 patients (84%).
Early results
The 1-year mortality rate was 8% (3/37). Two patients died within
3 months from sepsis: the first died on postoperative day 8, sec-
ondary to multiple organ failure, and the second on postoperative
day 68, 66 days after he had received a second graft, because of
initial acute PVT. Another patient did not recover from small-for-
size syndrome and eventually died at 12 months.
Four (11%) patients were retransplanted. Initial grafts included
one ERG and three RGs without the MHV. Indications comprised
PVT in two (included the deceased patient), acute hepatic artery
thrombosis in one, and primary non-function (PNF) in one.
Retransplantation occurred on postoperative days 1, 2, 4 and 6,
respectively.
The overall morbidity rate was 76% (29/38). Morbidity details
are reported in Table 4. A total of five (14%) patients required
re-operation. Postoperative haemoperitoneum occurred in three
cases and required re-operation on postoperative days 2, 2 and 3,
respectively. Bleeding originated from the raw cut surface in one
case, recipient IVC in one, and phrenic vein in one.
In addition to the three previously reported vascular complica-
tions, one patient developed a false aneurism of the hepatic artery
branch on postoperative day 47. He underwent successful radio-
logical embolization without arterial occlusion. Of note, neither
retransplantation nor vascular morbidity occurred in patients
with interposition of allogeneic or prosthetic vascular grafts.
Biliary complications occurred in six (16%) patients. Four bile
leaks occurred on postoperative days 4, 8, 9 and 22, respectively.
In one case bile leak externalized from the surgical drain healed
spontaneously; the others required endoscopic prosthesis (1), per-
cutaneous drainage (1) and re-operation (1). Bile leak originated
from the cut surface in two cases, the left hepatic duct stump in
one, and the cystic duct stump in one. One additional bile leak
occurred after the patient was discharged (on postoperative day
97) secondary to T-tube removal and required percutaneous
drainage. One bile duct stenosis occurred on postoperative day 43
and was treated by endoscopic stenting.
Among 31 ERGs, symptomatic segment IV necrosis occurred in
four (13%) cases. Three required percutaneous drainage and one
needed surgical necrosectomy.
Table 3 Characteristics of split-liver transplantation
IVC anastomosis n
IVC preservation 33
Graft with IVC: piggyback implantation 30
Graft without IVC: right hepatic vein to IVC 3
IVC replacement 5
Portal vein anastomosis n
Direct anastomosis 36
Iliac vein graft interposition 1
PTFE graft interposition to superior mesenteric vein 1
Hepatic artery implantation site n
Right branch from common hepatic artery 31
Right hepatic artery from superior mesenteric artery 4
Common hepatic artery + iliac artery graft 1
Splenic artery + iliac artery graft 1
Supra-coeliac aorta + iliac artery graft 1
Biliary anastomosis n
Duct-to-duct (with T-tube) 29 (12)
Choledocojejunostomy 9
IVC, inferior vena cava; PTFE, polytetrafluoroethylene
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Mortality and morbidity in patients with MELD scores <15
(n = 20) and >15 (n = 18) were 0% and 11%, and 65% and 89%,
respectively (P = NS).
Later results
After a mean follow-up of 52 months (range 12–177 months), the
overall 1-, 3- and 5-year patient survival rates were 91%, 88% and
78%, respectively (Fig. 1A). In addition to the three patients men-
tioned above, three patients died as a result of HCC recurrence, de
novo colorectal cancer and pulmonary embolism, respectively, at
22, 39 and 52 months, respectively.
One-, 3- and 5-year graft survival rates were 84%, 80% and
71%, respectively (Fig. 1A). According to the donor risk index,7
the expected median 1- and 3-year graft survival rates were 71.4%
and 60.0%, respectively.
Outcomes according to graft features
In situ vs. ex situ procedures
We compared outcomes for ERGs carried out using in situ vs. ex
situ splitting procedures (five vs. 26 cases). Cold ischaemic time
was significantly longer in the ex situ group (median 10 h vs. 8 h;
P = 0.005). In the five patients with in situ procurement, mortality
was nil and morbidity occurred in two cases and included one
urinary infection and one segment IV necrosis requiring drainage.
In the ex situ group, one patient died after retransplantation
(PVT) and morbidity occurred in 77% of cases. The incidence of
biliary complications was higher in the ex situ than the in situ
group (15% vs. 0%), but the difference was not significant
(Table 5). Post-transplant liver function tests and patient and graft
survival rates were similar across the two groups. All RGs were
split ex situ.
ERG vs. RG procedures
Only ex situ splitting procedures were included (seven RGs vs.
26 ERGs). Cold ischaemic time was significantly longer in RGs
(median 11 h vs. 10 h; P = 0.040). Mortality rates were higher in
RGs than in ERGs (14% vs. 4%), but the difference was not sig-
nificant. All patients in the RG group had postoperative morbidity
(100% vs. 77%). The retransplantation rate was significantly
higher in RG patients (43% vs. 4%; P = 0.023). One PNF and one
small-for-size syndrome occurred in RG patients, whereas none
occurred in ERG cases (29% vs. 0%; P = 0.04). Post-transplant
serum total bilirubin and INR peaks were significantly higher in
RG (median total bilirubin peak 396 mmol/l vs. 127 mmol/l, P =
0.008; median INR peak 3.6 vs. 2.2, P = 0.027). Patients in the RG
group had significantly lower survival (1-year survival 71% vs.
96%; P = 0.05). Graft survival was significantly lower in the RG
group (1 year survival 43% vs. 92%; P = 0.002) (Fig. 1B).
RG with or without the MHV
Of the five patients receiving RG without MHV, three required
retransplantation, including one for PNF, and one had small-for-
size syndrome. No retransplantation or liver dysfunction occurred
Table 4 Postoperative results
Graft Overall
(n = 38)
ERG (n = 31) RG (n = 7)
Mortality 1 (3%) 1 2 (5%)
Overall morbidity 22 (71%) 7 29 (76%)
Primary non-function – 1a 1 (3%)
Retransplantation 1 3 4
Vascular complications
Portal vein thrombosis 1a (3%) 1a,b 2 (5%)
Hepatic artery thrombosis – 1a 1 (3%)
Hepatic artery false aneurysms 1 (3%) – 1 (3%)
Biliary complications
Leak 3 (10%) 2 5 (13%)
Stenosis 1 (3%) – 1 (3%)
Segment IV necrosis 4 (13%) – 4 (11%)
Haemoperitoneum 1 (3%) 2 3 (8%)
Small-for-size syndrome – 1c 1 (3%)
Infectious complications 14b (45%) 5 19 (50%)
Pulmonary complications 18 (58%) 2 20 (53%)
aRetransplantation cases
bPatient death
cPatient died at 12 months without recovery of liver function
ERG, extended right graft; RG, right graft
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in the two patients with MHV. One-year graft survival in RG
without the MHV was 20% vs. 100% in RG with the MHV.
Discussion
More than 20 years after the first description of SLT,1,2 the spread
of this procedure remains limited. It provides excellent left grafts
for paediatric transplantation,9,10 but outcomes in adults are
controversial.4–8 This study confirms the suggestion that the split-
ting procedure can provide good grafts in adult recipients too,
with short- and long-term outcomes similar to those reported
after whole liver transplantation. Results are mainly related to
graft features: ERGs (i.e. segments I, IV–VIII) allow excellent out-
comes, but the risk of graft loss is significantly increased in RGs
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Figure 1 Survival outcome. (A) Overall patient and graft survival. (B) Patient and graft survival according to graft features: extended right graft
(ERG) vs. right graft (RG) (P = 0.05 and P = 0.002, respectively)
Table 5 Outcomes according to technical features: extended right grafts vs. right grafts generated by ex situ procedures; right grafts with
or without the middle hepatic vein
Ex situ P-value Right graft
ERG RG With MHV Without MHV
n 26 7 2 5
Cold ischaemia, h, mean (range) 10 (6–14) 11 (9–15) 0.040 12.5 (10–15) 11 (9–15)
Transplantation duration, min, mean (range) 420 (330–900) 435 (360–660) NS 390 (360–420) 540 (360–660)
Mortality 1 (4%) 1 NS – 1
Morbidity 20 (77%) 7 NS 2 5
Retransplantation 1 (4%) 3 0.023 – 3
PNF/small-for-size – 2 0.040 – 2
Vascular morbidity 2 (8%) 2 NS – 2
Biliary morbidity 4 (15%) 2 NS 1 1
1-year patient survival 96% 71% 0.050 100% 60%
1-year graft survival 92% 43% 0.002 100% 20%
ERG, extended right graft; RG, right graft; MHV, middle hepatic vein; NS, non-significant; PNF, primary non-function
200 HPB
HPB 2010, 12, 195–203 © 2010 International Hepato-Pancreato-Biliary Association
(i.e. segments V–VIII), particularly if the graft is deprived of the
MHV.
Outcomes of SLT have significantly improved over the last 10
years. Initial experiences reported high morbidity and graft loss
rates,3,11,12 whereas recent series have achieved results similar to
those in whole-liver transplantation thanks to better donor and
recipient selection and improved surgical technique.13,14,19–25
However, SLT is still considered a high-risk procedure and three
recent, large cohort studies have confirmed this.4,5,7 In a US survey
published in 2004, SLT was associated with increased risk for graft
failure and death in right graft recipients in comparison with
non-marginal whole-liver recipients.4 Two studies published in
2006, from Europe and the USA, studied graft outcomes in>30 000
and >20 000 liver transplantations, respectively.5,7 Split-liver trans-
plantation was associated with increased 3-month mortality in the
European study and was an independent negative predictive factor
of graft loss in the American one. The latter study proposed a donor
risk index in order to predict graft survival according to the pres-
ence of identified negative prognostic factors. On the basis of that
score, the predicted median 1- and 3-year graft survival rates in our
series were 71.4% and 60.0%. Our results are clearly superior to the
expected outcomes: 1-year patient and graft survival rates were
91% and 84% across the whole series, and exceeded 96% and 92%,
respectively, for ERG cases only.
Three aspects of SLT influence its outcomes: donor selection;
patient selection, and technical features.
Adequate selection of donors is the first step towards achieving
good SLT results. In this series only grafts from young patients
(median donor age 23 years, 65% < 30 years old) with normal liver
parenchyma and liver function tests were accepted. These charac-
teristics guarantee good graft tolerance to the splitting procedure
and to the increased cold and warm ischaemia necessarily associ-
ated with SLT. The modification of the French allocation system
in 2004 further improved this strategy by instigating a system
whereby donor livers aged < 30 years are offered to paediatric
recipients, which has stimulated SLT. Our excellent results,
obtained by using good quality grafts, support this graft selection
process.
As elucidated by early SLT experiences, recipient selection is
also recommended. Urgent transplantation has been reported as a
contraindication to partial liver transplantation because of the
increased risk for graft loss.19,21,22,26 In the US survey, the high
mortality rate of right graft recipients was mainly related to the
high rate of urgent SLT.4 In our series SLT was preferentially used
in elective patients with mild or moderate liver insufficiency. The
ratio of SLT over whole graft was significantly higher in patients
with PSC and HCC in comparison with patients with end-stage
cirrhosis (27% and 10%, respectively, vs. 3%; P < 0.05). These data
reflect the intention to offer split grafts to patients with limited
liver dysfunction who might otherwise expect a lengthy wait. In
particular, we consider PSC the best indication for SLT because
young recipients can receive high-quality liver parenchyma from
young donors with reduced waiting times. This policy resulted in
outcomes similar to or better than those of whole-liver transplan-
tation and better than those expected by the donor risk index.7 It
should also be noted that 18 patients in the present series with
MELD scores >15 showed increased mortality and morbidity
compared with 20 patients with lower MELD scores, although
the difference was not significant (11% vs. 0% and 89% vs.
65%, respectively). At present, MELD-adapted allocation policy
enhances this strategy because patients with severe liver function
impairment have quicker access to transplantation and therefore
do not require SLT.
Technical features are the third and main element influencing
SLT outcomes. The majority of split procedures, in this series and
others, provide ERGs13,14,22 and RGs are only required when a
bigger left graft recipient is selected (large child or adult). To date
few cases of RG have been reported, mainly in two-adult SLT.17,27
In the US survey only 6% of the procedures provided RGs.4
Although an ERG has a larger volume as a result of the inclusion
of segments IV and I, these segments are usually non-functional
or only partly functional because of the compromised blood
supply necessarily associated with the split procedure (the entire
left portal pedicle remains with the left graft). In addition, their
inadequate vascularization can lead to postoperative necrosis and
sepsis.3,16 Only one paper in 2007 directly compared outcomes of
ERG and RG (deprived of the MHV) and reported no difference
in terms of both morbidity and survival.23 In our series few
RGs were transplanted, but they were associated with significantly
increased morbidity and graft loss rates; three of seven patients
required retransplantation and another case developed small-for-
size syndrome that led to death 12 months after transplantation.
In ERG symptomatic segment IV necrosis occurred in 13% of
cases; this was usually managed by percutaneous drainage and
never led to graft loss. Negative outcomes of RG were mainly
related to the loss of the MHV. All cases with MHV omission had
post-transplant morbidity, 60% required retransplantation and
40% had PNF or small-for-size syndrome. By contrast, the two
patients who received an RG which included the MHV had good
graft function. This can be related to the fact that omission of the
MHV is associated with right anterior sector (segments V and
VIII) congestion, which reduces functional liver mass and impairs
liver regeneration.17,28,29 This has been clearly demonstrated in
living-donor liver transplantation29,30 and seems more critical in
SLT, leading in the latter to unacceptably high graft loss. Recon-
struction of the MHV tributaries has been attempted in living-
donor liver transplantation with good results.29,30 In 2005, the
Hamburg group proposed splitting the MHV along Cantlie’s line
and reconstructing on both sides in order to preserve good venous
outflow into the two grafts.17 The problem of sharing the MHV is
one of the main reasons for the very limited development of full
right/full left SLT in two adults and is confirmed by this study.
Two further technical issues should be considered.
The first concerns the sharing of the arterial axis. In this series,
unlike in other reports,3,15,31 the coeliac trunk always remained
with the left graft by agreement with the paediatric surgeons.
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Right branch–right branch anastomosis was performed in the
majority of cases, as in living-donor liver transplantation, whereas
iliac graft interposition was used in three patients. Despite
increased technical difficulty, only one patient had arterial
thrombosis.
The second technical issue concerns intraoperative cholangiog-
raphy. Some authors recommend that cholangiography should
be regularly performed during the splitting procedure in order
to identify anatomical variations and to avoid biliary lesions
during dissection.11,12 In the present series, cholangiography was
performed in early cases, including all in situ splits. However, we
stopped using cholangiography in recent cases. We found the yield
of ex situ cholangiography to be low compared with its logistical
demands, especially for our usual procedure of ERG/LLG. We
believe that biliary anatomy can be assessed by inserting an
atraumatic metallic cannula into the common bile duct.
Our results underline the claim that adult + child pair SLT
(ERG/LLG) is a safe procedure and should be widely encouraged.
As suggested by some authors, SLT could replace living-donor
liver transplantation in children, without worsening outcomes in
adult recipients.14,32 In theory, 30% of transplantable livers could
be split,13,21 but the real percentage is actually much lower. In the
American survey, only 40% of transplant centres had experience
with SLT and only 13 teams had performed more than five pro-
cedures.4 In our centre, SLT represents about 10% of transplanta-
tions. Adequate policy to improve the spread of SLT should be
adopted. However, adult + adult SLT or any splitting procedure
generating RG should be cautiously evaluated. Although RGs are
commonly used in living-donor liver transplantation with good
results, SLT with RG is associated with increased risk for mortality
and graft loss. Longer cold ischaemic time, prolonged re-warming
during ex situ splitting procedures and poorer graft quality from
deceased donors may explain these outcomes. Right grafts with
the MHV are more likely to be transplanted successfully; however,
the context in which a full right/full left split transplant is appro-
priate involves a larger recipient of the left graft, who also requires
the MHV. Therefore, until further refinements are available, we
will no longer consider RG transplantation.
A further topic of debate involves procurement technique. In
situ splitting has been proposed by the Hamburg and UCLA
(University of California, Los Angeles) groups in order to improve
haemostasis and biliostasis, to reduce cold ischaemic time, to
avoid liver re-warming during bench surgery, and to assess
adequate segment IV vascularization in ERG.15,31 However, in situ
splitting prolongs procurement time and requires haemodynamic
stability of the donor. Only one paper has directly compared the
results of in situ and ex situ splitting procedures and reported no
difference in adult recipients.33 In the present series, the in situ
procedure was associated with shorter ischaemic time and a
reduced biliary complication rate, but did not demonstrate any
advantages in terms of haemorrhagic complications, segment IV
necrosis, post-transplant graft function or patient and graft sur-
vival. Thus, given our excellent results with ERGs procured ex situ
and the logistical problems and low acceptance by other procure-
ment teams of the in situ technique, we have adopted ex situ
splitting as our routine technique.
In conclusion, SLT is a safe alternative to whole-liver transplan-
tation if an ERG is provided. Donor selection is necessary in order
to provide grafts with excellent quality parenchyma that can tol-
erate the challenge of the splitting procedure. Recipient selection
is recommended and patients with mild or moderate liver dys-
function should be preferred for SLT. Whereas ERG guarantees
excellent outcomes, RG is associated with increased risk for graft
loss, especially if the MHV is omitted. Although the in situ split-
ting procedure can reduce cold ischaemia time and postoperative
biliary complications, the ex situ technique yields identical short-
and long-term outcomes. Split-liver transplantation that provides
an ERG for an adult recipient and an LLG for a child should be
encouraged when good quality grafts are available.
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